Zaghi, I; Ielasi, L; Stagni, B; Cascavilla, A; Ferri, S; Ambrosini, V; Riefolo, M; Varani, S, A case of Leishmania infection with focal splanchnic involvement without systemic symptoms: a potential anti-inflammatory role for vitamin D, «ACTA CLINICA BELGICA», 2022, 2022 Nov 14, pp. 1 - 4 [Scientific article]
Zanoni L.; Argalia G.; Fortunati E.; Malizia C.; Allegri V.; Calabro D.; Civollani S.; Campana D.; Fanti S.; Ambrosini V., Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2022, 49, pp. 1607 - 1612 [Scientific article]
Evangelista L.; Pietrzak A.; Ekmekcioglu O.; Ovcaricek P.P.; Ambrosini V.; Balogova S.; Cunha L.; Eccles A.; Garibotto V.; Lewington V.; Israel O.; Kunikowska J., Gender issues in the nuclear medicine community: results from a survey promoted by the EANM Women Empowerment Task Force, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2022, 49, pp. 2106 - 2112 [Scientific article]
Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; Casadei R.; Campana D., Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis, «CANCER MEDICINE», 2022, 11, pp. 4204 - 4213 [Scientific article]Open Access
Fortunati E.; Argalia G.; Zanoni L.; Fanti S.; Ambrosini V., New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms, «CURRENT TREATMENT OPTIONS IN ONCOLOGY», 2022, 23, pp. 703-720 - 720 [Scientific article]Open Access
Ambrosini, Valentina; Zanoni, Lucia; Filice, Angelina; Lamberti, Giuseppe; Argalia, Giulia; Fortunati, Emilia; Campana, Davide; Versari, Annibale; Fanti, Stefano, Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors, «CANCERS», 2022, 14, pp. 1055 - 1083 [Scientific article]Open Access
Magi L.; Prosperi D.; Lamberti G.; Marasco M.; Ambrosini V.; Rinzivillo M.; Campana D.; Gentiloni G.; Annibale B.; Signore A.; Panzuto F., Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors, «ENDOCRINE», 2022, 76, pp. 1392 - 1399 [Scientific article]Open Access
Zanoni L.; Calabro D.; Fortunati E.; Argalia G.; Malizia C.; Allegri V.; Civollani S.; Fanti S.; Ambrosini V., Two birds with one stone: can [68Ga]Ga-DOTANOC PET/CT image quality be improved through BMI-adjusted injected activity without increasing acquisition times?, «BRITISH JOURNAL OF RADIOLOGY», 2022, 95, Article number: 20211152. , pp. 1 - 9 [Scientific article]Open Access
Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; Ricci C.; Casadei R.; Fanti S.; Ambrosini V., [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?, «CANCERS», 2022, 14, Article number: 3541 , pp. 1 - 10 [Scientific article]Open Access
Alessandro Bevilacqua, Diletta Calabrò, Silvia Malavasi, Claudio Ricci, Riccardo Casadei, Davide Campana, Serena Baiocco, Stefano Fanti, Valentina Ambrosini, A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours, «DIAGNOSTICS», 2021, 11, Article number: 870 , pp. 1 - 16 [Scientific article]Open Access
Dall'Olio FG, Calabrò D, Conci N, Argalia G, Marchese PV, Fabbri F, Fragomeno B, Ricci D, Fanti S, Ambrosini V, Ardizzoni A., Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab., «EUROPEAN JOURNAL OF CANCER», 2021, 150, pp. 99 - 107 [Scientific article]
Pantaleo M.A.; Mandruzzato M.; Indio V.; Urbini M.; Nannini M.; Gatto L.; Schipani A.; Fiorentino M.; Franceschini T.; Ambrosini V.; Di Scioscio V.; Saponara M.; Ianni M.; Concetti S.; Altimari A.; Ardizzoni A.; Astolfi A., Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 633543 , pp. 1 - 9 [Scientific article]Open Access
Silvia Malavasi, Diletta Calabrò, Alessandro Bevilacqua, Claudio Ricci, Riccardo Casadei, Davide Campana, Stefano Fanti, Valentina Ambrosini, Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT, in: ECR 2021 – BOOK OF ABSTRACTS, «INSIGHTS INTO IMAGING», 2021, pp. 1 - 1 (atti di: The 33rd European Congress of Radiology (ECR 2021), Vienna (Austria), March 3-7, 2021) [Abstract]
Ambrosini V.; Kunikowska J.; Baudin E.; Bodei L.; Bouvier C.; Capdevila J.; Cremonesi M.; de Herder W.W.; Dromain C.; Falconi M.; Fani M.; Fanti S.; Hicks R.J.; Kabasakal L.; Kaltsas G.; Lewington V.; Minozzi S.; Cinquini M.; Oberg K.; Oyen W.J.G.; O'Toole D.; Pavel M.; Ruszniewski P.; Scarpa A.; Strosberg J.; Sundin A.; Taieb D.; Virgolini I.; Wild D.; Herrmann K.; Yao J., Consensus on molecular imaging and theranostics in neuroendocrine neoplasms, «EUROPEAN JOURNAL OF CANCER», 2021, 146, pp. 56 - 73 [Scientific article]
Mei R.; Allegri V.; Calabro D.; Fanti S.; Ambrosini V., Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET/CT detection of primary duodenal neuroendocrine tumor (NET), «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 1684 - 1685 [Scientific article]
